We sought to identify a secreted biomarker for -catenin activation commonly seen in hepatocellular carcinoma (HCC). developing HCC with Ctnnb1 mutations showed significantly higher serum LECT2 levels. However patients with mutations showed LECT2 levels of 54.2822.32 ng/mL (Mean SD; n?=?8) that were insignificantly different from patients with non-neoplastic chronic liver disease (32.821.1 ng/mL; n?=?15) or… Continue reading We sought to identify a secreted biomarker for -catenin activation commonly